Q+A: Why a Singapore investor is betting on Brisbane’s biotech future

About this episode

The episode discusses Brisbane's emergence as a biotech hub and features an interview with John Ratcliffe about investment in the area.

Brisbane is rapidly emerging as one of Australia's most important healthcare and life sciences hubs, and global investors are taking notice. Sean Aylmer speaks with John Ratcliffe, CEO of Altea Investments, about the company's decision to launch a new life sciences incubator at QIMR Berghofer Medical Research Institute. They also discuss how AI is accelerating scientific research, and why global capital increasingly follows talent rather than geography. Fear & Greed is working with the Brisbane Economic Development Agency to explore why international businesses are choosing Brisbane. Find out more: https://fearandgreed.com.au/ See omnystudio.com/listener for privacy information.

People in this episode

Host: Sean Aylmer

Guest: John Ratcliffe

Topics covered

• biotech
• healthcare
• life sciences
• AI in research
• investment
• Brisbane

Keywords

• Brisbane
• biotech
• healthcare
• AI
• investment
• life sciences
• John Ratcliffe

Mentioned in this episode

Organizations: Altea Investments, QIMR Berghofer Medical Research Institute

Places: Brisbane, Singapore, Australia

More episodes of FEAR & GREED | Business News

• The Saturday Edition | 13 June 2026 · June 12, 2026 · 30 min
• Afternoon Report | ASX ends week on high · June 12, 2026 · 4 min
• SpaceX lift-off entices local investors, Aust to buy jet fuel from China, World Cup kick-off · June 11, 2026 · 18 min
• Afternoon Report | ASX dips on Middle East flare-up · June 11, 2026 · 5 min
• Sigma mulls $14b bid for UK chemist; A$ heads south; airline profits plunge · June 10, 2026 · 18 min
• Q+A: Wesfarmers CEO Rob Scott on AI, Bunnings and what worries him · June 10, 2026 · 13 min